Discovery of Novel Tofacitinib–ADTOH Molecular Hybridization Derivatives for the Treatment of Ulcerative Colitis
The treatment of ulcerative colitis (UC) has been a major medical challenge due to the lack of safe and effective drugs. Molecular hybridization is a promising strategy for the development of drugs with pleiotropic activity, which has been demonstrated in a wide range of diseases. Tofacitinib has ex...
Saved in:
| Main Authors: | Yi Mou, Shuai Wen, Yan Wang, Yao Zhao, Ying-Ping Li, Hong-Kai Sha, Li-Juan Gui, Zheng-Yu Jiang, Xiang-Ming Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Antioxidants |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3921/14/3/325 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Tofacitinib on Hemostasis in Patients with Ulcerative Colitis: A Comparative Ex Vivo Study
by: Cristina Sánchez-Sánchez, et al.
Published: (2025-04-01) -
Small Molecules in the Treatment of Acute Severe Ulcerative Colitis: A Review of Current Evidence
by: Raffaele Pellegrino, et al.
Published: (2025-02-01) -
Tofacitinib downregulates JAK1 and JAK3 on human intestinal monocytes and macrophages without affecting dendritic cells phenotype or function
by: Elisa Arribas-Rodríguez, et al.
Published: (2025-06-01) -
Colorectal cancer risk in ulcerative colitis: an updated population-based systematic review and meta-analysisResearch in context
by: Lechang Zhang, et al.
Published: (2025-06-01) -
The growing potential of tofacitinib in immune checkpoint inhibitor-induced colitis: identifying remaining puzzle pieces
by: Raffaele Pellegrino, et al.
Published: (2024-11-01)